Our team combines proven investment acumen with the scientific background necessary to analyze the risks and complexities of early-stage life science investing. Our expertise encompasses the range of venture financing, biomedical research, entrepreneurship, operational management, product development, and strategic partnering. The team works closely with Mass General Brigham’s extensive network of clinical and scientific experts to source opportunities and validate them as commercially viable concepts.